Long-term skin allograft survical elicited by a finite treatment with antilymphocyte serum combined with cytarabine.
D000818:Animals; D000961:Antilymphocyte Serum / Q000494:pharmacology*; D003561:Cytarabine / Q000494:pharmacology*; D004357:Drug Synergism; D005260:Female; D006648:Histocompatibility / Q000187:drug effects*; D007122:Immunoelectrophoresis; D051379:Mice; D011485:Protein Binding; D051381:Rats; D016038:Skin Transplantation; D014181:Transplantation Immunology; D014183:Transplantation, Heterologous; D014184:Transplantation, Homologous; D014316:Tritium
D000961:Antilymphocyte Serum; D003561:Cytarabine; D014316:Tritium